{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:51:18Z","timestamp":1771512678957,"version":"3.50.1"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1001\/archderm.141.3.301","type":"journal-article","created":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T16:19:13Z","timestamp":1111421953000},"page":"301","source":"Crossref","is-referenced-by-count":11,"title":["Low-Dose Bexarotene and Low-Dose Interferon Alfa-2b for Adult T-Cell Leukemia\/Lymphoma Associated With Human T-Lymphotropic Virus 1"],"prefix":"10.1001","volume":"141","author":[{"given":"Stephen","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne B.","family":"Budgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M.","family":"Junkins-Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela C.","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Wallace T.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"REF-DCE40007-1","unstructured":"BJPoieszFWRuscettiAFGazdarPABunnJDMinnaRCGalloDetection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProc Natl Acad Sci U S A198077741574196261256"},{"key":"REF-DCE40007-2","unstructured":"RFEdlichJAArnetteFMWilliamsGlobal epidemic of human T-cell lymphotropic virus type-I (HTLV-I)J Emerg Med20001810911910645850"},{"key":"REF-DCE40007-3","unstructured":"RSiegelRGartenhausTKuzelHTLV-I associated leukemia\/lymphoma: epidemiology, biology, and treatmentCancer Treat Res2001104758811191136"},{"key":"REF-DCE40007-4","unstructured":"MShimoyamaDiagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87)Br J Haematol1991794284371751370"},{"key":"REF-DCE40007-5","unstructured":"OHermineDBouscaryAGessainBrief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfaN Engl J Med1995332174917517760891"},{"key":"REF-DCE40007-6","unstructured":"PSGillWHarringtonJrMHKaplanTreatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudineN Engl J Med1995332174417487760890"},{"key":"REF-DCE40007-7","unstructured":"RMahieuxCPise-MasisonAGessainArsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavageBlood2001983762376911739184"},{"key":"REF-DCE40007-8","unstructured":"EFChanYGDowdyBLeeA novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destructionJ Am Acad Dermatol1999401161219922028"},{"key":"REF-DCE40007-9","unstructured":"TAWaldmannJDWhiteCKGoldmanThe interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I\u2013induced adult T-cell leukemiaBlood199382170117128400227"},{"key":"REF-DCE40007-10","unstructured":"DZucker-FranklinThe role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphomaAnn N Y Acad Sci2001941869611594585"},{"key":"REF-DCE40007-11","unstructured":"MDuvicKHymesPHealdBexarotene Worldwide Study GroupBexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial resultsJ Clin Oncol2001192456247111331325"},{"key":"REF-DCE40007-12","unstructured":"KRSuchinAJCucchiaraSLGottleibTreatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institutionArch Dermatol20021381054106012164743"},{"key":"REF-DCE40007-13","unstructured":"KSMcGinnisJMJunkins-HopkinsGCrawfordMShapiroAHRookCCVittorioLow-dose oral bexarotene in combination with low-dose interferon alpha in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanismsJ Am Acad Dermatol20045037537914988678"},{"key":"REF-DCE40007-14","unstructured":"CCVittorioJMJunkins-HopkinsKSMcGinnisNew biologic agents for the treatment of cutaneous T-cell lymphomaRecent Results Cancer Res200216032132812079230"},{"key":"REF-DCE40007-15","unstructured":"AHRookMKubinMCassinIL-12 reverses cytokine and immune abnormalities in Sezary syndromeJ Immunol1995154149114987822812"},{"key":"REF-DCE40007-16","unstructured":"RSgoncGBoeckHDietrichJGruberHRecheisGWickSimultaneous determination of cell surface antigens and apoptosisTrends Genet19941041428191583"},{"key":"REF-DCE40007-17","unstructured":"NHastrupERalfkiaerGPallesenAberrant phenotypes in peripheral T cell lymphomasJ Clin Pathol1989423984022469701"},{"key":"REF-DCE40007-18","unstructured":"FMFossSLAquinoJAFerryCase records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 10-2003: a 72-year-old man with rapidly progressive leukemia, rash, and multiorgan failureN Engl J Med20033481267127512660391"},{"key":"REF-DCE40007-19","unstructured":"YMaedaJMiyatakeHSono13-cis retinoic acid inhibits growth of adult T cell leukemia cells and causes apoptosis: possible new indication for retinoid therapyIntern Med1996351801848785449"},{"key":"REF-DCE40007-20","unstructured":"HNawataYMaedaYSumimotoJMiyatakeAKanamaruA mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax\/NF-kappaB signaling pathwayLeuk Res20012532333111248329"},{"key":"REF-DCE40007-21","unstructured":"CZhangPHazarikaXNiDAWeidnerMDuvicInduction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic actionClin Cancer Res200281234124012006543"},{"key":"REF-DCE40007-22","unstructured":"MMontoyaGSchiavoniFMatteiType I interferons produced by dendritic cells promote their phenotypic and functional activationBlood2002993263327111964292"},{"key":"REF-DCE40007-23","unstructured":"FBelardelliMFerrantiniEProiettiJMKirkwoodInterferon-alpha in tumor immunity and immunotherapyCytokine Growth Factor Rev20021311913411900988"}],"container-title":["Archives of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/392980\/dce40007_301_304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:03:18Z","timestamp":1764968598000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/392980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archderm.141.3.301","relation":{},"ISSN":["0003-987X"],"issn-type":[{"value":"0003-987X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}